Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results

19023 Background: In a prior phase I trial we combined a new oral platinum analogue (S) with P in patients (pts) with refractory malignancies, and found this regimen to be safe (Invest New Drugs 20...